Report Categories
View AllRecent Articles
View All
GDHG Golden quarterly earnings released with limited financial data as investors await detailed breakdown
VCEL Vericel Corporation reports 131 percent Q4 2025 EPS beat shares fall 623 percent in todays trading
Where could Portland POR stock be by the end of 2026 Q4 2025 Earnings Underperform
How Mesabi Trust MSB thinks about risk management Mesabi Trust posts 021 EPS with no published consensus estimates
Trump Delays AI Executive Order Citing Concerns Over Potential Restrictions
Golds Bearish Trend Worsens Amid Diminishing Peace Deal Expectations
Amazon and GE Vernova Among Stocks Approaching Key Levels as Market Strength Persists
Standard Chartered CEO Apologizes After Referring to Workers as Lower Value Human Capital
China Boosts Coal Reserves to 30Day Supply as El Nino Threat Looms
Iran Emerges Stronger in Geopolitical Standoff Analysts Suggest
FWONA Q4 2025 Earnings Modest EPS Miss Amid Steady Operational Progress
MGTX Q1 2026 Earnings Missed EPS Estimates as PreRevenue Biotech Advances Pipeline
Scholar Rock Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline
MEC Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction
HLX Q1 2026 Earnings EPS Misses Estimates Amid Challenging Conditions
NVNI Q4 2025 Earnings Massive EPS Miss Amidst Absence of Revenue Data
Lixte Biotechnology LIXT Slides 525 as Stock Tests Key Support at 532
CVS Health Stock Edges Higher as Traders Eye Support and Resistance Levels
Eaton Vance TaxManaged BuyWrite Opportunities Fund ETV Edges Higher as Income Strategy Attracts Steady Interest
Sizzle Acquisition Corp II SZZL Holds Steady Near Support in Quiet Trading Session
NPK International Inc NPKI Falls 086 as Stock Approaches Key Support Level
UniFuels Holdings UFG Slips 318 as Stock Tests Key Support Near 067
SRX Health Solutions Inc SRXH Faces Selling Pressure Near Key Support
Liquidia Corporation LQDA Slips Amidst Market Caution Key Support Levels in Focus
Caseys General Stores CASY Slides Over 3 as Resistance Holds Firm
Gesher Acquisition Corp II Warrants Hold Steady at 022 as Trading Range Tightens
Compass Therapeutics CMPX Breaks Above Support Whats Driving the 46 Move